Local institutional review board (IRB) review of a multicenter trial: local costs without local context
- PMID: 20225291
- PMCID: PMC2848288
- DOI: 10.1002/ana.21831
Local institutional review board (IRB) review of a multicenter trial: local costs without local context
Abstract
Multicenter clinical research involves parallel Institutional Review Board (IRB) reviews based on the premise that local review reflects aspects of the research environment. We examined the costs and effects of local IRB review of the consent and protocol in a multicenter clinical trial in Parkinson disease. Seventy-six percent of changes to the consent reflected standard institutional language, with no substantive changes to the protocol. The costs of this process exceeded $100,000. These findings support initiatives by the Office of Human Research Protections (OHRP) and the National Cancer Institute (NCI) to facilitate centralized reviews. This may be an opportune time for the National Institute of Neurological Disorders and Stroke (NINDS) to adopt a central review model.
References
- 
    - Menikoff J. Advanced notice of proposed rulemaking; request for comments. Vol. 74. Federal Register; 2009. pp. 9578–9583.
 
- 
    - Cooperative Research. Federal Register; 2005. Code of Federal Regulations. Title 45, Part 46.114.
 
- 
    - National Conference on Alternative IRB Models: Optimizing Human Subject Protection; 2006. AAMC: http://www.aamc.org/research/irbreview/start.htm.
 
- 
    - Burman W, Breese P, Weis S, et al. The effects of local review on informed consent documents from a multicenter clinical trials consortium. Control Clin Trials. 2003;24:245–255. - PubMed
 
- 
    - Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed-consent forms as compared with actual readability. N Engl J Med. 2003;348:721–726. - PubMed
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
 
        